• NIA Innovations & COVID-19
  • Newsletter Sign-Up
  • FAQs
  • Case Studies
  • Contact Us
NIANIANIANIA
  • About
    • What the NIA offers
    • Selection Process
    • Core Team
    • Mentors
    • Partners
    • Collaborate
    • Apply
  • Fellows and Innovations
    • Overview
    • Fellows
    • Innovations
    • Alumni
  • Latest
    • Events
    • News & blogs

Ideas for how intellectual property could enable rather than hinder

    Home Blogs Ideas for how intellectual property could enable rather than hinder
    NextPrevious

    Ideas for how intellectual property could enable rather than hinder

    By admin | Blogs | Comments are Closed | 14 August, 2018 | 0

    The complexities and challenges around intellectual property (IP) are well-recognised by clinician entrepreneurs as a major barrier to the development, adoption and spread of innovation in the NHS. Peter Young, NIA Fellow and a Consultant in Anesthesia and Critical Care, shares his thoughts on how IP could enable rather than hinder.

    The UK is recognised for inventiveness and innovation, and consistently ranks in the top ten of Nobel laureates per capita – outranking the USA by nearly 2:1. However, in a 2013 report, the top 100 global innovators failed to include any UK businesses.

    In 2002, the Department of Health published a framework on the management of Intellectual Property (IP) within the NHS, to guide senior NHS managers as to how to manage IP generated by all NHS employees for income generation.

    This informed the policies of NHS Trusts and defined contractual requirements across the NHS. Whilst well-meaning, this may have inadvertently adversely affected the freedom to innovate for clinician innovators and entrepreneurs.

    The framework declared that: “…generally speaking, UK law provides that (unless otherwise agreed) IP produced by employees in the course of their employment or normal duties belongs to the employer,” and also that: “…new terms of contract would make it clear that making and reporting innovations and inventions is part of every employee’s duties.”

    This position could be reasonably challenged by clinicians (with the financial resources to do so), however the legal ambiguity of the situation at an early stage can prevent the ability to successfully engage with industry, at a time when the idea may have little real value prior to substantial investment and development.

    Clinical entrepreneurs and innovators recognise that an idea and the associated IP is worth nothing to patients or financial managers unless developed into a successful and implemented product. It is the ability to drive this process that takes 99% of the effort, passion and investment. Profit share arrangements of most Trusts are laudable but miss the point. There must be freedom for the innovator to choose (with encouragement and help where available) the direction, investment and re-investment of resources during this navigation of ‘the valley of death’ to transform a fledgling innovation to realise a global product. This is what is needed to avoid snuffing out innovation in its infancy.

    The worst scenario is a common position where a normally cash-strapped Trust, inexpert in this field, cannot provide the required time, expertise or resources outside of their core services to reasonably support an innovation or innovator at the level required to succeed – but by policy owns and controls the IP.

    Proven successful models in US tech industries celebrate and free-up entrepreneurs through individual IP ownership. This helps to build businesses, generate jobs and wealth, and most importantly enables the realisation and ultimate uptake of innovation for the benefit of the economy and most importantly for the end beneficiaries – the patients.

    I am often approached by other clinical entrepreneurs and innovators to share my learnings and experience. If their primary motivation is personal financial gain, my advice is to stick to the day job! Entrepreneurship requires passion, risk, sacrifice and the freedom to follow the best path for your innovation. Financial sustainability and a lifetime of re-investment of all profits is the key to reaching your destination.

    If the end game is to provide good for humanity, then innovators in the NHS need support from their institution and national bodies, within a safe or even celebrated environment where ‘conflicts of interest’ are embraced as necessary, and even desirable. Most importantly, they need to have a greater freedom to operate. There is a growing mass of individuals and institutions within the NHS who understand and support these goals. The hope is that this may soon be reflected in policy to inform a cultural change at the grassroots.

    No tags.

    Related Posts

    • The new palliative care gold standard

      By admin | Comments are Closed

      By: Julia Riley The EIU’s recent Quality of Death report praised palliative care in the UK as the best in the world, citing the quality and availability of services provided by the NHS and hospice movement as “second toRead more

    • Nervecentre Software win prestigious Building Better Healthcare Award

      By admin | Comments are Closed

      Nervecentre Software in partnership with Nottingham University Hospitals NHS Trust have won the prestigious award for ‘Best Communications and IT product’ at the Building Better Healthcare Awards, held on 4th November 2015, The award isRead more

    • Southend University Hospital NHS Foundation Trust live with Nervecentre electronic observations

      By admin | Comments are Closed

      Southend University Hospital NHS Foundation Trust has now deployed Nervecentre Electronic Observations software using mobiles devices across the hospitals to improve patient safety and communications. Funded through the Nursing Technology Fund, Electronic Observations are now liveRead more

    • Nervecentre in Australia… Success at the ISRRS Symposium in Melbourne


      By admin | Comments are Closed

      Written by Jim Trueman Attendees of the symposium held by the International Society for Rapid Response Systems and Medical Emergency Teams are all clinicians that intuitively recognise the problems that Nervecentre was designed to solve. Read more

    • i-THRIVE: Manchester and Salford’s Integrated Access and Care Pathways 


      By admin | Comments are Closed

      What was the problem you were trying to solve? Central Manchester University Hospitals NHS Foundation Trust (CMFT) provide child and adolescent mental health services (CAMHS) for Manchester and Salford. The move towards Integrated Access andRead more

    • Coordinate My Care Integrates Care Plans into Emis Web

      By admin | Comments are Closed

      Urgent care plans for thousands of London’s most vulnerable patients care are now just a click away for almost 1,000 of their GPs. Plan sharing scheme Coordinate my Care will now be available to 962Read more

    • OWise breast cancer app proven to be effective tool in cancer treatment process

      By admin | Comments are Closed

      Innovative patient support app shown in peer-reviewed medical journal to improve patient-doctor interactions and is recommended by 90% of patients and clinicians OWise breast cancer, the first mobile app to offer patients personalised medical supportRead more

    • OBH featured in TeleMedicine Magazine

      By admin | Comments are Closed

      Telemedicine Magazine included an article on Outcome Based Healthcare (OBH) in their series focusing on the growing trend of doctors getting involved with healthcare start-ups. Rupert, OBH CEO, explained that during his time as aRead more

    NextPrevious
    Contact Us
    nia@uclpartners.com
    @NHSAccelerator
    Newsletter Sign-Up
    Terms and Conditions | Privacy and Cookies
    NHS Innovation Accerlator
    Copyright 2017 NHS Innovation Accelerator
    • Menu
      • Latest
      • Case Studies
      • News and Events
      • Press and Media
      • FAQs (OLD)
      • Contact Us
    • Apply
    • Fellows and Innovations
      • Fellows
      • Innovations
    • Collaborate
    • Accelerator
      • Partners
      • What the NIA offers
      • Selection Process
      • Mentors
    NIA